ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor
1
H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, bs = broad singlet, m = multiplet), and integration. Melting points ( o C) are uncorrected. Thin-layer chromatography (TLC) was performed on glass plates coated with silica gel (0.2 mm, 60 F254) and flash column chromatography using silica gel (200-400 mesh). HR-MS spectra were obtained using a UHPLC-MS n Orbitrap Velos-Thermo mass spectrometer.
5α-Androstane-3β,6α,17β-triol (2)
To a stirred solution of dehydroepiandrosterone (1) (5.0 g, 17.34 mmol) in THF (75 mL) at -10°C under N 2 was added 1M BH 3 •THF complex in THF (44 mL, 44 mmol). After completing the addition, the bath was removed and the mixture was stirred at room temperature for 5 h. The reaction was cooled to 0°C and H 2 O (85 mL) was cautiously added dropwise, followed by NaBO 3 •4H 2 O (5.23 g, 34 mmol). After stirring at room temperature overnight, the solid was filtered, washed with THF (3 × 50 mL) and then discarded. The organic phase was separated and the aqueous phase was saturated with NaCl and extracted with THF (3 × 50 mL). The combined organic extracts were dried over Na 2 SO 4 , filtered, and evaporated in vacuo to dryness. The crude product was crystallized from EtOAc/MeOH (2/1, 10 mL/g) to give a first crop of compound 2 as a white solid (2.7 g). The mother liquors were evaporated and the residue crystallized from EtOAc/MeOH (2/1, 10 mL/g) to give a second crop of compound 2 as a white solid (0.94 g). The procedure was repeated to give a third crop of compound 2 as a white solid (0.37 g); (In total 4.01 g; 75% overall yield).
Mp Androstane-3, 6,17-trione (3) To a solution of 5α-androstane-3β,6α,17β-triol (2) (2.9 g, 9.4 mmol) in acetone (74 mL) was added an excess of Jones reagent (11 mL) dropwise, maintaining the temperature below 35°C. 5 min after completion of the addition, the excess of Jones reagent was neutralised by addition of i-PrOH (13.5 mL) and after further 10 min stirring, the suspension was filtered from a short silica pad and the filtrate evaporated to dryness. The residue was treated with H 2 O (50 mL) and extracted with EtOAc (3 × 60 mL). The combined organic extracts were washed with 5% aqueous NaHCO 3 solution (50 mL), H 2 O (50 mL), dried over Na 2 SO 4 and evaporated to dryness. The residue was purified by flash column chromatography (elution solvent, DCM:MeOH, 98:2) to give 5α-androstane-3, 6,17-trione (3) as a white solid (2.1 g, 74% 
5α-

(E, Z) 3-(2-Aminoethoxyimino)-5α-androstane-6, 17-trione (4)
To a stirred solution of 5α-androstane-3, 6,17-trione (3) (1.83 g, 6.05 mmol) in THF (40 mL), a solution of the 2-aminoethoxyamine dihydrochloride (894 mg, 6 mmol) (Pankaskie and Scholtz 1989) in H 2 O (19 mL) was rapidly added dropwise. After 1.5 h, NaCl (2.63 g, 45 mmol) was added and the mixture was stirred for 10 min. The layers were separated and the aqueous layer was extracted with THF (3 × 50 mL). The combined organic extracts were dried over Na 2 SO 4 , filtered, and evaporated to give an oily residue. The crude product was dissolved in CH 2 Cl 2 (0.15 M) and washed with a saturated aqueous solution of NaCl (3 × 30 mL). The organic layer was dried again over Na 2 SO 4 and evaporated to dryness. The crude product was crystallized from MeOH/EtOAc to afford the HCl salt of (E, Z) 3-(2-aminoethoxyimino)-5α-androstane-6, 17-trione (4), 1.33 g 56% yield as a white solid.
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